Cargando…
Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
Background: Therapy with oral anticoagulation (OAC) can be challenging, especially in high risk groups such as chronic patients. Gaps in patient knowledge about OAC are linked to reduced effectiveness and safety of treatment. The objectives of this study were i) to assess OAC knowledge gathered duri...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355591/ https://www.ncbi.nlm.nih.gov/pubmed/32231095 http://dx.doi.org/10.3390/pharmacy8020054 |
_version_ | 1783558311647379456 |
---|---|
author | Metaxas, Corina Albert, Valerie Habegger, Susanne Messerli, Markus Hersberger, Kurt E. Arnet, Isabelle |
author_facet | Metaxas, Corina Albert, Valerie Habegger, Susanne Messerli, Markus Hersberger, Kurt E. Arnet, Isabelle |
author_sort | Metaxas, Corina |
collection | PubMed |
description | Background: Therapy with oral anticoagulation (OAC) can be challenging, especially in high risk groups such as chronic patients. Gaps in patient knowledge about OAC are linked to reduced effectiveness and safety of treatment. The objectives of this study were i) to assess OAC knowledge gathered during an intermediate medication review (MR) in patients taking vitamin K antagonists (VKA) or non-vitamin K antagonist oral anticoagulants (NOAC); ii) to assess OAC knowledge two weeks after the MR, and iii) to evaluate patient satisfaction with the MR service in community pharmacies. Methods: Chronic OAC patients were invited for a regular MR service in Swiss community pharmacies, the so-called “Polymedication-Check” (PMC). OAC knowledge was assessed with seven newly generated items asked face-to-face during a PMC and by telephone two weeks later. Knowledge gaps, pharmacists’ spontaneous interventions, and patient satisfaction were documented by observing pharmacy students. Treatment groups were compared. Results: Of all patients (n = 81), the number of patients with one or more knowledge gaps decreased from 66% to 31.3% after PMC (p < 0.001). NOAC patients (n = 31) had more knowledge gaps than VKA patients (n = 50; p < 0.05). Most patients (98.6%) were satisfied with the counselling provided by the pharmacists. Conclusion: The majority of chronic OAC patients shows knowledge gaps. Although spontaneous, the provision of tailored education during a PMC increased patient OAC knowledge. |
format | Online Article Text |
id | pubmed-7355591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73555912020-07-23 Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies Metaxas, Corina Albert, Valerie Habegger, Susanne Messerli, Markus Hersberger, Kurt E. Arnet, Isabelle Pharmacy (Basel) Article Background: Therapy with oral anticoagulation (OAC) can be challenging, especially in high risk groups such as chronic patients. Gaps in patient knowledge about OAC are linked to reduced effectiveness and safety of treatment. The objectives of this study were i) to assess OAC knowledge gathered during an intermediate medication review (MR) in patients taking vitamin K antagonists (VKA) or non-vitamin K antagonist oral anticoagulants (NOAC); ii) to assess OAC knowledge two weeks after the MR, and iii) to evaluate patient satisfaction with the MR service in community pharmacies. Methods: Chronic OAC patients were invited for a regular MR service in Swiss community pharmacies, the so-called “Polymedication-Check” (PMC). OAC knowledge was assessed with seven newly generated items asked face-to-face during a PMC and by telephone two weeks later. Knowledge gaps, pharmacists’ spontaneous interventions, and patient satisfaction were documented by observing pharmacy students. Treatment groups were compared. Results: Of all patients (n = 81), the number of patients with one or more knowledge gaps decreased from 66% to 31.3% after PMC (p < 0.001). NOAC patients (n = 31) had more knowledge gaps than VKA patients (n = 50; p < 0.05). Most patients (98.6%) were satisfied with the counselling provided by the pharmacists. Conclusion: The majority of chronic OAC patients shows knowledge gaps. Although spontaneous, the provision of tailored education during a PMC increased patient OAC knowledge. MDPI 2020-03-28 /pmc/articles/PMC7355591/ /pubmed/32231095 http://dx.doi.org/10.3390/pharmacy8020054 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Metaxas, Corina Albert, Valerie Habegger, Susanne Messerli, Markus Hersberger, Kurt E. Arnet, Isabelle Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies |
title | Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies |
title_full | Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies |
title_fullStr | Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies |
title_full_unstemmed | Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies |
title_short | Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies |
title_sort | patient knowledge about oral anticoagulation therapy assessed during an intermediate medication review in swiss community pharmacies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355591/ https://www.ncbi.nlm.nih.gov/pubmed/32231095 http://dx.doi.org/10.3390/pharmacy8020054 |
work_keys_str_mv | AT metaxascorina patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies AT albertvalerie patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies AT habeggersusanne patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies AT messerlimarkus patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies AT hersbergerkurte patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies AT arnetisabelle patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies |